<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".05" citation="COMAR 10.09.58.05" title_num="10" subtitle_num="09" chapter_num="58" heading="Covered Services.">
  <text>The following services are covered under this chapter:</text>
  <paragraph num="A.">
    <text>Office medical visits for the primary purpose of providing age and sex appropriate family planning services, which include:</text>
    <paragraph num="(1)">
      <text>Focused history, physical exam, and laboratory testing necessary to evaluate and manage the participant’s choice of chemical, mechanical, or other method to prevent conception;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Basic education regarding human sexuality and reproduction;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Advice and counseling regarding all family planning methods, including natural family planning measures and sterilization procedures, the availability and effectiveness of methods, procedures involved in each, and untoward effects and potential complications of each method; and</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Referral mechanism and documented referral for all patients demonstrating illness, disease, or pregnancy;</text>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>Specimen collection by venipuncture or capillary puncture when performed by either the medical practitioner or the laboratory;</text>
  </paragraph>
  <paragraph num="C.">
    <text>Pregnancy test if indicated by physical examination or history, or both, when performed by either the medical practitioner or the laboratory;</text>
  </paragraph>
  <paragraph num="D.">
    <text>The following laboratory tests:</text>
    <paragraph num="(1)">
      <text>Hemoglobin or hematocrit, or both;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Urinalysis for albumin sugar;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Urine culture and sensitivity studies;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Appropriate laboratory tests to screen for sexually transmitted infections;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Smear wet mount and KOH with interpretation;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Rubella titer of females without documentation of prior rubella immunization; and</text>
    </paragraph>
    <paragraph num="(7)">
      <text>Pap smear;</text>
    </paragraph>
  </paragraph>
  <paragraph num="E.">
    <text>Pharmaceutical supplies and devices:</text>
    <paragraph num="(1)">
      <text>To prevent conception through chemical, mechanical, or other methods, which are covered by the Maryland Medical Assistance Program under COMAR 10.09.03.04; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>To treat sexually transmitted infections when diagnosed during the course of an office visit, as outlined in §A of this regulation, which are covered under COMAR 10.09.03.04 except treatment for:</text>
      <paragraph num="(a)">
        <text>Human immunodeficiency virus; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Hepatitis.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="F.">
    <text>Permanent sterilization only when performed according to criteria in 42 CFR Part 441, Subpart F, Sterilizations, as amended, and when the appropriate forms are:</text>
    <paragraph num="(1)">
      <text>Properly completed; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Available in the medical record for review;</text>
    </paragraph>
  </paragraph>
  <paragraph num="G.">
    <text>Human papillomavirus vaccine; and</text>
  </paragraph>
  <paragraph num="H.">
    <text>Abortions performed in accordance with Health-General Article, §15-103, Annotated Code of Maryland.</text>
  </paragraph>
</regulation>